With
the help of two technology companies, CTE
and eHealthWare, One of the global Pharmaceutical
conglomerates. has successfully automated
its clinical drug trial procedures, which
will result in reduced development costs and
time to market. In recognizing that its manual
drug trial processes were cumbersome and could
be streamlined by entering the digital age,
the company enlisted the help of eHealthWare,
Inc. (eHW), and CTE to create and implement
a software solution.
It takes on average $350
to $500 million and eight to ten years for
a drug to come to market, and much of that
time and money is absorbed by clinical trials.
The traditional, paper-based system used for
recording, compiling and processing clinical
trial data is unable to support the growing
volume of information required of today's
clinical trials. eHealthWare and CTE worked
closely with this large Pharmaceutical enterprise
to fully gauge the complexities of every stage
of its trials. The companies were able to
immediately identify how computer technology
could make this large Pharmaceutical enterprise’s
processes more efficient.
CTE specializes in Urgentware
– software that helps businesses resolve
time-critical problems – as well as solutions
that work with customers’ existing systems
to significantly improve their operations.
For this large Pharmaceutical enterprise, eHealthWare and CTE
built a customized application that would
work with its existing enterprise systems
to:
-
Automatically collect
results of drug trials from each this
large Pharmaceutical enterprise office
and subsidiary
-
In real-time, assimilate
that data into a central analysis and
reporting repository
-
Validate the data
by cross-referencing it with standards
built into the software
-
Use intelligent agents
to detect problems through user-defined
rules, alert criteria and escalation procedures
-
Create automatic notifications
about the status of the process (e.g.
failure, success, etc.)
-
Automate the report
generation and distribution process
-
Enable users to identify,
isolate and recover from problems in real-time
using wireless devices.
“Automating certain aspects
of the clinical drug trial process results
in a remarkable reduction in time to market
and drug development costs,” says Himanshu
Raval, this large Pharmaceutical enterprise
Senior Manager, Global Business Technology.
“It will reduce costs, but on a broader level,
it will provide us with a way to significantly
expedite our development processes, increasing
the numbers of medications we can provide
to a public that is more and more in need
of them.”
“With the software solution,
this large Pharmaceutical enterprise expects
that each clinical drug trial will take less
time and money,” continued Raval. “Time to
market will be decreased, thus enhancing the
revenue potential for each pharmaceutical.”
CTE (www.ctepl.com)
is a privately held company headquartered
in Cambridge, Mass. It was founded in 1999
with the goal of providing a development platform
for rapid mobile application deployment.
eHealthWare, Inc. (www.ehealthware.com)
develops software applications and provides
related support services to the pharmaceutical,
biotechnology and medical devices industries.
It is located in Massachusetts.
The large Pharmaceutical
enterprise discovers, develops, manufactures
and markets leading prescription medicines
for humans and animals, and many of the world's
best-known consumer products. this large Pharmaceutical
enterprise had global revenues of $29.6 billion
in 2000.
About CTE
CTE, a CMMI Level 5 next-generation business
lifecycle solutions provider, has a focus
on building and integrating business applications.
CTE’s core competency lies in its collaborative
delivery model, a solution delivery approach
that aligns business, technical, and user
stakeholders; includes partner technologies
and services as necessary; and delivers end-to-end
solutions on a fixed price and fixed time
frame basis.
CTE’s business model is based on a global
delivery model foundation, which stays close
to the customer and yet optimizes the value
of the solution offered.
For more information, please visit www.ctepl.com
or e-mail us at info@ctepl.com.
|